Standards for Reducing Risks Associated with ePMA for SACT

By Netty Cracknell on 29 May 2019

It is with great pleasure to announce that the BOPA Standards for Reducing Risks Associated with ePMA for SACT have been updated and can be found in the publication section of the members only section of the website.
 
These BOPA Standards for Reducing Risks Associated with Electronic Prescribing and Medicines Administration Systems (ePMA) for Systemic Anti-Cancer Therapies (SACT) outlines steps that can be considered to be best practice in reducing the risks of errors arising from the introduction and use of e-prescribing systems for SACT within organisations.
 
If you have any queries please direct them to netty.cracknell@ramsayhealth.co.uk
 
Close
Close
Close